Increased Use of Biochips in Healthcare Applications to Boost the Growth of Biochips Market
Biochips Market |
The global Biochips Market is estimated to be valued at US$ 10.71 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent
Market Insights.
Market Overview:
Biochips are miniature lab devices containing microarrays of biochemical assays.
They enable researchers to analyze large numbers of biomolecules
simultaneously. Biochips are used in applications related to genomics,
proteomics, and other fields. They utilize sophisticated fabrication
technologies tominiaturize and parallelize complex biochemical assays and
reactions.Biochips offer several advantages over traditional biochemical
techniques such ashigh-throughput analysis, low sample volume requirement,
reduced timelines, low cost, andportability. Growing applications in drug
discovery and healthcare are fueling demand for biochips.
Market key trends:
One of the major trends in the biochips market is the increasing adoption of
microarray technology. Microarrays allow researchers to analyze thousands of
biomolecular interactions simultaneously. Technologies such as DNA microarrays
and protein microarrays are widely used for diagnostic testing, gene expression
analysis, and other purposes. Advancements in microarray fabrication techniques
have increased probe densities, reduced feature sizes, and enhanced sensitivity
of detection. Growing investments by industry players to develop newer
generations of microarrays will support market growth over the forecast period.
Label-free detection is another upcoming trend, enabled by technologies like
surface Plasmon resonance which allow real-time analysis without use of labels.
This offers advantages like reduced assay time, simplified workflow and lower
costs.
Porter’s Analysis for Biochips Market
Threat of new entrants: The threat of new entrants in the biochips market is
low as it requires high R&D investment and established distribution
network. Existing players have economies of scale.
Bargaining power of buyers: The bargaining power of buyers is moderate as there
are many players operating in the market providing substitutable products.
Bargaining power of suppliers: The bargaining power of suppliers is low due to
availability of substitute raw materials and less differentiation in parts and
components.
Threat of new substitutes: The threat of new substitutes is moderate as
technology is continuously evolving and new advanced biosensors are emerging as
substitutes.
Competitive rivalry: The competitive rivalry in the market is high due to
presence of many global and regional players competing on basis of quality,
price and innovation.
Key Takeaways
The
Global Biochips Market Demand is expected to witness high growth,
exhibiting CAGR of 12% over the
forecast period, due to increasing demand for point-of-care testing and
personalized medicine. The market size for 2023
is US$ 10.71 Bn. North America dominates the global biochips market
accounting for maximum share due to presence of major players and advancements
in biotechnology and genomics research. Asia Pacific is expected to witness
fastest growth owing to growing R&D activities, rising healthcare
expenditure and increasing demand for POC diagnostics in countries like India
and China.
Key players operating in the biochips market are Thermo Fisher Scientific,
Inc., Agilent Technologies, Inc., PerkinElmer Inc., Illumina, Inc., Bio-Rad
Laboratories, Inc., Standard BioTools, GE HealthCare, Thermo Fisher Scientific,
Inc., LI-COR, Inc., QIAGEN, Randox Laboratories Ltd. Thermo Fisher Scientific
dominates the market with wide product portfolio and geographical presence
across the globe.
Read More:
https://www.marketwebjournal.com/biochips-market-demand-forecast-and-growth/
Comments
Post a Comment